Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cardiology
Biotech
Imbria hits safety benchmark in phase 2 heart failure test
Imbria’s heart failure medicine met the safety and tolerability goals in a phase 2 trial but also improved results on a cardiopulmonary exercise test.
Annalee Armstrong
Nov 7, 2023 9:55am
Fallout from Quantum Genomics' phase 3 fail claims executives
Feb 22, 2023 2:06pm
Ultrasound AI outperforms human clinicians in randomized study
Aug 27, 2022 3:40pm
Scientists test mRNA vaccines to fix heart damage in mice
Apr 30, 2022 7:00am
Acutus Medical plans layoffs to cut costs amid rising revenues
Jan 20, 2022 11:52am
Lilly extends JPM collab theme in $1B Evotec pact, Abbisko deal
Jan 18, 2022 11:30am